To determine the role of NAP1L1 and HDGF in glioma, we analysed the protein level expressions of NAP1L1 and HDGF by immunostaining in 108 glioma tissues and 24 para-tumor tissues (Figure 6A). The gene discussed is HDGF; the disease is central nervous system cancer.